Cargando…

Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership

OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Feltz-Cornelis, Christina Maria, Sweetman, Jennifer, Edwards, Mark, Gall, Nicholas, Gilligan, Jennifer, Hayle, Stephanie, Kaul, Arvind, Moriarty, Andrew Stephen, Perros, Petros, Sampford, James, Smith, Natalie, Elfeddali, Iman, Varley, Danielle, Gower, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252198/
https://www.ncbi.nlm.nih.gov/pubmed/35777869
http://dx.doi.org/10.1136/bmjopen-2022-061263
_version_ 1784740211925712896
author van der Feltz-Cornelis, Christina Maria
Sweetman, Jennifer
Edwards, Mark
Gall, Nicholas
Gilligan, Jennifer
Hayle, Stephanie
Kaul, Arvind
Moriarty, Andrew Stephen
Perros, Petros
Sampford, James
Smith, Natalie
Elfeddali, Iman
Varley, Danielle
Gower, Jonathan
author_facet van der Feltz-Cornelis, Christina Maria
Sweetman, Jennifer
Edwards, Mark
Gall, Nicholas
Gilligan, Jennifer
Hayle, Stephanie
Kaul, Arvind
Moriarty, Andrew Stephen
Perros, Petros
Sampford, James
Smith, Natalie
Elfeddali, Iman
Varley, Danielle
Gower, Jonathan
author_sort van der Feltz-Cornelis, Christina Maria
collection PubMed
description OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the James Lind Alliance (JLA) approach. Research into such symptoms in general has been poorly funded over the years and so far has been primarily researcher-led with minimal input from patients, caregivers and clinicians; and sometimes has been controversial. DESIGN: JLA PSP method. The PSP termed these symptoms MNYES. METHODS: The study was conducted according to the JLA’s detailed methodology for conducting priority setting exercises. It involved five key stages: defining the appropriate term for the conditions under study by the PSP Steering Group; gathering questions on MNYES from patients, caregivers and clinicians in a publicly accessible survey; checking these research questions against existing evidence; interim prioritisation in a second survey; and a final multi-stakeholder consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: Over 700 responses from UK patients, caregivers and clinicians were identified in the two surveys and charities contributed from a broad range of medical specialties and primary care. The final top 10 unanswered research questions cover, among others: treatment strategies, personalisation of treatment, collaborative care pathways, training for clinicians and outcomes that matter to patients. INTERPRETATION: The top 10 unanswered research questions are expected to generate much needed, relevant and impactful research into MNYES.
format Online
Article
Text
id pubmed-9252198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92521982022-07-05 Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership van der Feltz-Cornelis, Christina Maria Sweetman, Jennifer Edwards, Mark Gall, Nicholas Gilligan, Jennifer Hayle, Stephanie Kaul, Arvind Moriarty, Andrew Stephen Perros, Petros Sampford, James Smith, Natalie Elfeddali, Iman Varley, Danielle Gower, Jonathan BMJ Open Evidence Based Practice OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the James Lind Alliance (JLA) approach. Research into such symptoms in general has been poorly funded over the years and so far has been primarily researcher-led with minimal input from patients, caregivers and clinicians; and sometimes has been controversial. DESIGN: JLA PSP method. The PSP termed these symptoms MNYES. METHODS: The study was conducted according to the JLA’s detailed methodology for conducting priority setting exercises. It involved five key stages: defining the appropriate term for the conditions under study by the PSP Steering Group; gathering questions on MNYES from patients, caregivers and clinicians in a publicly accessible survey; checking these research questions against existing evidence; interim prioritisation in a second survey; and a final multi-stakeholder consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: Over 700 responses from UK patients, caregivers and clinicians were identified in the two surveys and charities contributed from a broad range of medical specialties and primary care. The final top 10 unanswered research questions cover, among others: treatment strategies, personalisation of treatment, collaborative care pathways, training for clinicians and outcomes that matter to patients. INTERPRETATION: The top 10 unanswered research questions are expected to generate much needed, relevant and impactful research into MNYES. BMJ Publishing Group 2022-07-01 /pmc/articles/PMC9252198/ /pubmed/35777869 http://dx.doi.org/10.1136/bmjopen-2022-061263 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Evidence Based Practice
van der Feltz-Cornelis, Christina Maria
Sweetman, Jennifer
Edwards, Mark
Gall, Nicholas
Gilligan, Jennifer
Hayle, Stephanie
Kaul, Arvind
Moriarty, Andrew Stephen
Perros, Petros
Sampford, James
Smith, Natalie
Elfeddali, Iman
Varley, Danielle
Gower, Jonathan
Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
title Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
title_full Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
title_fullStr Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
title_full_unstemmed Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
title_short Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
title_sort identifying the top research priorities in medically not yet explained symptoms (mnyes): a james lind alliance priority setting partnership
topic Evidence Based Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252198/
https://www.ncbi.nlm.nih.gov/pubmed/35777869
http://dx.doi.org/10.1136/bmjopen-2022-061263
work_keys_str_mv AT vanderfeltzcornelischristinamaria identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT sweetmanjennifer identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT edwardsmark identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT gallnicholas identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT gilliganjennifer identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT haylestephanie identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT kaularvind identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT moriartyandrewstephen identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT perrospetros identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT sampfordjames identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT smithnatalie identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT elfeddaliiman identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT varleydanielle identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership
AT gowerjonathan identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership